Internal medicine, Fatty liver, Nonalcoholic fatty liver disease, Gastroenterology and Endocrinology are his primary areas of study. His work in Insulin resistance, Steatosis, Steatohepatitis, Liver biopsy and Fibrosis are all subfields of Internal medicine research. His studies in Fatty liver integrate themes in fields like Body mass index, Liver disease and Diabetes mellitus, Metabolic syndrome.
The Nonalcoholic fatty liver disease study combines topics in areas such as Chronic liver disease, Cirrhosis, Weight loss and Hepatology. His Gastroenterology research is multidisciplinary, relying on both Nonalcoholic steatohepatitis, Cytokeratin 18 Fragment and Receiver operating characteristic. His Endocrinology research incorporates themes from Gene silencing, Biochemistry and PTEN.
Valerio Nobili mainly focuses on Internal medicine, Gastroenterology, Fatty liver, Nonalcoholic fatty liver disease and Endocrinology. His Internal medicine study focuses mostly on Steatosis, Insulin resistance, Fibrosis, Steatohepatitis and Metabolic syndrome. His Gastroenterology research is multidisciplinary, incorporating perspectives in Body mass index, Liver biopsy and Genotype.
His Fatty liver research is multidisciplinary, relying on both Immunology, Obesity and Type 2 diabetes. His research in Nonalcoholic fatty liver disease intersects with topics in Weight loss, Cirrhosis, Hepatology and Intensive care medicine. His biological study spans a wide range of topics, including Pediatrics and Bioinformatics.
Valerio Nobili focuses on Internal medicine, Nonalcoholic fatty liver disease, Gastroenterology, Fatty liver and Disease. His research on Internal medicine frequently links to adjacent areas such as Endocrinology. He interconnects Obesity, Liver biopsy, Transient elastography and Chronic liver disease, Cirrhosis in the investigation of issues within Nonalcoholic fatty liver disease.
His research integrates issues of Body mass index, Diabetes mellitus, Metabolic syndrome and Genotype in his study of Gastroenterology. His Fatty liver research focuses on Fibrosis and how it relates to Inflammation, Procollagen peptidase and Receiver operating characteristic. His Disease study incorporates themes from Pediatrics, Bioinformatics and Intensive care medicine.
His main research concerns Internal medicine, Nonalcoholic fatty liver disease, Gastroenterology, Disease and Fatty liver. The Internal medicine study which covers Endocrinology that intersects with FGF19. His Nonalcoholic fatty liver disease research integrates issues from Oxidative stress, Liver biopsy, Transient elastography, Weight loss and Liver disease.
His Gastroenterology study combines topics in areas such as Cohort, Genotype and Vitamin E. His studies deal with areas such as Cirrhosis, Obesity, Epidemiology and Family medicine as well as Disease. Valerio Nobili focuses mostly in the field of Fatty liver, narrowing it down to topics relating to Fibrosis and, in certain cases, Procollagen peptidase and Receiver operating characteristic.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease
Giulio Marchesini;Christopher P. Day;Jean Francois Dufour;Ali Canbay.
Journal of Hepatology (2016)
Homozygosity for the patatin-like phospholipase-3/adiponutrin i148m polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease
Luca Valenti;Ahmad Al‐Serri;Ann K. Daly;Enrico Galmozzi.
Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee.
Pietro Vajro;Selvaggia Lenta;Piotr Socha;Anil Dhawan.
Journal of Pediatric Gastroenterology and Nutrition (2012)
Nonalcoholic fatty liver disease
Elizabeth M. Brunt;Vincent W.-S. Wong;Valerio Nobili;Christopher P. Day.
Nature Reviews Disease Primers (2015)
Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: A randomized, controlled trial
Valerio Nobili;Melania Manco;Rita Devito;Vincenzo Di Ciommo.
NAFLD in children: A prospective clinical‐pathological study and effect of lifestyle advice
Valerio Nobili;Matilde Marcellini;Rita Devito;Paolo Ciampalini.
Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis
Valerio Nobili;Francesco Vizzutti;Umberto Arena;Juan G. Abraldes.
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent
Rosellina Margherita Mancina;Paola Dongiovanni;Salvatore Petta;Piero Pingitore.
Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis.
A. Alisi;G. Bedogni;G. Baviera;V. Giorgio.
Alimentary Pharmacology & Therapeutics (2014)
Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease.
Valerio Nobili;Julie Parkes;Gianfranco Bottazzo;Matilde Marcellini.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: